Last reviewed · How we verify
Atropine Sulfate Ophthalmic Solution — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Atropine Sulfate Ophthalmic Solution (Atropine Sulfate Ophthalmic Solution) — Biomedical Advanced Research and Development Authority.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Atropine Sulfate Ophthalmic Solution TARGET | Atropine Sulfate Ophthalmic Solution | Biomedical Advanced Research and Development Authority | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Atropine Sulfate Ophthalmic Solution CI watch — RSS
- Atropine Sulfate Ophthalmic Solution CI watch — Atom
- Atropine Sulfate Ophthalmic Solution CI watch — JSON
- Atropine Sulfate Ophthalmic Solution alone — RSS
Cite this brief
Drug Landscape (2026). Atropine Sulfate Ophthalmic Solution — Competitive Intelligence Brief. https://druglandscape.com/ci/atropine-sulfate-ophthalmic-solution. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab